{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:53:04Z","timestamp":1792144384572,"version":"4.4.0"},"reference-count":46,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007664","name":"Manpei Suzuki Diabetes Foundation","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/501100007664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["Grant Number JP20ek0210105"],"award-info":[{"award-number":["Grant Number JP20ek0210105"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2021,3,28]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Preventing the development and progression of diabetic microvascular complications through optimal blood glucose control remains an important challenge. Whether metrics based on continuous glucose monitoring are useful for the management of diabetic microvascular complications is not entirely clear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>This is an exploratory analysis of an ongoing prospective, multicenter, 5-year follow-up observational study. Study participants included 999 outpatients with type 2 diabetes who underwent continuous glucose monitoring at baseline. Associations between continuous glucose monitoring-derived metrics and the severity of diabetic retinopathy or albuminuria were investigated using multivariable proportional odds models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The overall prevalence of diabetic retinopathy was 22.2%. Multivariate analysis with proportional odds models demonstrated that continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy, even after adjusting for various possible risk factors. However, significant relationships were not observed after adjusting for hemoglobin A1c (HbA1c) levels. The prevalence of microalbuminuria and macroalbuminuria was 20.3% and 6.7%, respectively. Similarly, multivariate analysis demonstrated that those metrics are significantly associated with the severity of albuminuria. These relationships remained significant even after further adjusting for HbA1c levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Continuous glucose monitoring-derived metrics related to intraday and interday glucose variability are significantly associated with the severity of diabetic retinopathy or albuminuria in patients with type 2 diabetes. Thus, evaluating these metrics might possibly be useful for risk assessment of diabetic microvascular complications.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial registration number<\/jats:bold>\n                      UMIN000032325.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2020-001923","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T20:04:27Z","timestamp":1618949067000},"page":"e001923","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes"],"prefix":"10.1136","volume":"9","author":[{"given":"Satomi","family":"Wakasugi","sequence":"first","affiliation":[{"name":"Department of Metabolism & Endocrinology, Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-2965","authenticated-orcid":false,"given":"Tomoya","family":"Mita","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology, Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Katakami","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan"},{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okada","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Yoshii","sequence":"additional","affiliation":[{"name":"Department of Medicine, Diabetology & Endocrinology, Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Osonoi","sequence":"additional","affiliation":[{"name":"Nakakinen Clinic, Naka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Nishida","sequence":"additional","affiliation":[{"name":"Nishida Keiko Diabetes Clinic, Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Shiraiwa","sequence":"additional","affiliation":[{"name":"Shiraiwa Medical Clinic, Kashihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Torimoto","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kurozumi","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Gosho","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Watada","sequence":"additional","affiliation":[{"name":"Department of Metabolism & Endocrinology, Juntendo University School of Medicine Graduate School of Medicine, Bunkyo-ku, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"2025073112163830000_9.1.e001923.1","doi-asserted-by":"publisher","DOI":"10.1080\/09286580701396720"},{"key":"2025073112163830000_9.1.e001923.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32064-5"},{"key":"2025073112163830000_9.1.e001923.3","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420190068008"},{"key":"2025073112163830000_9.1.e001923.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"2025073112163830000_9.1.e001923.5","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.8.968"},{"key":"2025073112163830000_9.1.e001923.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"2025073112163830000_9.1.e001923.7","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(95)01064-K"},{"key":"2025073112163830000_9.1.e001923.8","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S006"},{"key":"2025073112163830000_9.1.e001923.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13340-018-0345-3","article-title":"Japanese clinical practice guideline for diabetes 2016","volume":"9","author":"Haneda","year":"2018","journal-title":"Diabetol Int"},{"key":"2025073112163830000_9.1.e001923.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808431"},{"key":"2025073112163830000_9.1.e001923.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4169"},{"key":"2025073112163830000_9.1.e001923.12","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0063"},{"key":"2025073112163830000_9.1.e001923.13","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.11.2795"},{"key":"2025073112163830000_9.1.e001923.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2727"},{"key":"2025073112163830000_9.1.e001923.15","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"2025073112163830000_9.1.e001923.16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/jdi.12957","article-title":"Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type\u00a02 diabetes","volume":"10","author":"Lu","year":"2019","journal-title":"J Diabetes Investig"},{"key":"2025073112163830000_9.1.e001923.17","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1131"},{"key":"2025073112163830000_9.1.e001923.18","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/liv.14322","article-title":"Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score","volume":"40","author":"Xin","year":"2020","journal-title":"Liver Int"},{"key":"2025073112163830000_9.1.e001923.19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7888\/juoeh.40.11","article-title":"Association between diabetic microangiopathies and glycemic variability assessed by continuous glucose monitoring","volume":"40","author":"Sonoda","year":"2018","journal-title":"J Uoeh"},{"key":"2025073112163830000_9.1.e001923.20","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s13300-019-0665-8","article-title":"Protocol of a prospective observational study on the relationship between glucose fluctuation and cardiovascular events in patients with type 2 diabetes","volume":"10","author":"Mita","year":"2019","journal-title":"Diabetes Ther"},{"key":"2025073112163830000_9.1.e001923.21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"2025073112163830000_9.1.e001923.22","doi-asserted-by":"publisher","DOI":"10.2337\/diab.19.9.644"},{"key":"2025073112163830000_9.1.e001923.23","doi-asserted-by":"publisher","DOI":"10.1089\/152091503322527021"},{"key":"2025073112163830000_9.1.e001923.24","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2010.0247"},{"key":"2025073112163830000_9.1.e001923.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2018.01.003"},{"key":"2025073112163830000_9.1.e001923.26","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1909"},{"key":"2025073112163830000_9.1.e001923.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2199-0"},{"key":"2025073112163830000_9.1.e001923.28","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1444"},{"key":"2025073112163830000_9.1.e001923.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-020-01085-6","article-title":"Glycemic variability: adverse clinical outcomes and how to improve it?","volume":"19","author":"Zhou","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"2025073112163830000_9.1.e001923.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10924"},{"key":"2025073112163830000_9.1.e001923.31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5114\/aoms.2019.84739","article-title":"Glucose fluctuation increased mesangial cell apoptosis related to Akt signal pathway","volume":"15","author":"Ying","year":"2019","journal-title":"Arch Med Sci"},{"key":"2025073112163830000_9.1.e001923.32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1089\/dia.2019.0499","article-title":"Association between continuous glucose Monitoring-Derived time in range, other core metrics, and albuminuria in type 2 diabetes","volume":"22","author":"Yoo","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2025073112163830000_9.1.e001923.33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/dme.12607","article-title":"Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring","volume":"32","author":"Jin","year":"2015","journal-title":"Diabet Med"},{"key":"2025073112163830000_9.1.e001923.34","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"key":"2025073112163830000_9.1.e001923.35","article-title":"Severe hypoglycemia as a predictor of end-stage renal disease in type 2 diabetes: a national cohort study","volume":"16","author":"Lee","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2025073112163830000_9.1.e001923.36","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.12.1401"},{"key":"2025073112163830000_9.1.e001923.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(11)80780-6"},{"key":"2025073112163830000_9.1.e001923.38","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/jdi.12981","article-title":"Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type\u00a02 diabetes patients with diabetic nephropathy","volume":"10","author":"Shimizu","year":"2019","journal-title":"J Diabetes Investig"},{"key":"2025073112163830000_9.1.e001923.39","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-1"},{"key":"2025073112163830000_9.1.e001923.40","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-10-19"},{"key":"2025073112163830000_9.1.e001923.41","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1600"},{"key":"2025073112163830000_9.1.e001923.42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1932296816662884","article-title":"A multicenter evaluation of the performance and usability of a novel glucose monitoring system in Chinese adults with diabetes","volume":"11","author":"Ji","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"2025073112163830000_9.1.e001923.43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1479164118756240","article-title":"Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: implications for clinical practice","volume":"15","author":"Ajjan","year":"2018","journal-title":"Diab Vasc Dis Res"},{"key":"2025073112163830000_9.1.e001923.44","doi-asserted-by":"crossref","first-page":"dc192073","DOI":"10.2337\/dc19-2073","article-title":"Comparison of the FreeStyle Libre pro flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with Basal-Bolus insulin regimen","volume":"43","author":"Galindo","year":"2020","journal-title":"Diabetes Care"},{"key":"2025073112163830000_9.1.e001923.45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bcp.2017.05.001","article-title":"P2X7 receptor antagonism: implications in diabetic retinopathy","volume":"138","author":"Platania","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"2025073112163830000_9.1.e001923.46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/191497","article-title":"Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy","volume":"2014","author":"Malaguarnera","year":"2014","journal-title":"Biomed Res Int"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2020-001923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:16:44Z","timestamp":1753989404000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,4,20]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bmjdrc-2020-001923"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2020-001923","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-72340\/v1","asserted-by":"object"}]},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}